Rapid Micro Biosystems, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
Rapid Micro Biosystems, Inc. - Class A (RPID)
NASDAQ:AMEX Investor Relations:
money.cnn.com/news/newsfeeds/articles/marketwire/0649788.htm
Company Research
Source: Yahoo! Finance
Rapid Micro Biosystems, Inc. Q4 2025 Earnings Call Summary - Moby Strategic Performance and Operational Context Achieved record fourth quarter revenue of $11.3 million, representing 37% year-over-year growth and the 13th consecutive quarter of meeting or exceeding expectations. Performance was driven by a record 16 system placements in Q4, including a major global rollout with Amgen across North America, Europe, and Asia. Samsung Biologics is expanding its Growth Direct deployment with a new multisystem order in Q1 2026, validating the platform's role in next-generation manufacturing. Consumable revenue grew 17% for the full year, serving as a key indicator of active system utilization and realized ROI within the installed base. Total gross margin has improved by over 50 percentage points over the last three years, supported by ongoing manufacturing efficiencies and service productivity. The MilliporeSigma partnership is entering its second year with established demo la
Show less
Read more
Impact Snapshot
Event Time:
RPID
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RPID alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RPID alerts
High impacting Rapid Micro Biosystems, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
RPID
News
- Rapid Micro Biosystems (RPID) was upgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=RPID&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from "sMarketBeat
- Rapid Micro Biosystems (RPID) was downgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=RPID&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from MarketBeat
- Rapid Micro Biosystems: Big Pharma Adoption Driving Growth [Seeking Alpha]Seeking Alpha
- Rapid Micro Biosystems Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Guidance [Yahoo! Finance]Yahoo! Finance
- Rapid Micro Biosystems Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 GuidanceGlobeNewswire
RPID
Earnings
- 3/12/26 - Miss
RPID
Sec Filings
- 3/12/26 - Form 4
- 3/12/26 - Form 4
- 3/12/26 - Form 4
- RPID's page on the SEC website